TYRO3 and prostate carcinoma: Interestingly, one study suggests that the balance between AXL and TYRO-3 expression is important in the dormancy of prostate cancer cells, with high TYRO-3 levels promoting proliferation and high AXL expression leading to a quiescent phenotype [70].